0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
In Vitro Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: November 2019
|
Report Code: ALLI-Auto-0R304
Home | Category |Health
In Vitro Diagnostics IVD Market by Product Type Reagents Instruments and Software Services Technique Immunodiagnostics Enzyme Linked Immunosorbent Assay Chemiluminescence Immunoassay CLIA Fluorescence Immunoassay FIA and Colorimetric Immunoassay CI Rapid Tests Enzyme Linked ImmunoSpot ELISPOT Radioimmunoassay RIA and Western Blot Hematology Molecular Diagnostics Polymerize Chain Reaction PCR Isothermal Nucleic Acid Technology INAAT Hybridization DNA Diagnostics Microarray and Others Tissue Diagnostics Clinical Chemistry Basic Metabolic Panel Liver Panel Lipid Profile Thyroid Function Panel Electrolyte Panel and Specialty Chemicals and Other IVD Techniques Application Infectious Diseases Cancer Cardiac Diseases Immune System Disorders Nephrological Diseases Gastrointestinal Diseases and Other Indications and End User Standalone Laboratory Hospitals Academic Medical Schools Point of Care Testing and Others Global Opportunity Analysis and Industry Forecast 2018 2025

In Vitro Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-0R304
Report
November 2019
381 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

In Vitro Diagnostics (IVD) Market Overview:

 

The global in vitro diagnostics (IVD) market size was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. 

 

In vitro diagnostics (IVD) are medical devices, which require use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples collected from a patient. In addition, there are various types of in vitro diagnostic instruments that work on different techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are employed in diagnosis of various medical conditions such as infectious diseases, cancer, cardiac disorders, and nephrological disorders.  Moreover, use and handling of in vitro diagnostics require technical expertise and thus, instruments are used in specialized medical facilities to carry out diagnosis. For instance, IVD products are used in facilities such as standalone laboratories, hospitals, and point-of care. 

 

The major factor that contributes to the in vitro diagnostics market growth of the in vitro diagnostic market include surge in number of in vitro diagnostic tests, which is attributable to rise in incidences of chronic and infectious diseases. Furthermore, growth in geriatric population, which is prone to immunological disorders, is another major factor that boosts the growth of the market. Moreover, rise in use of personalized medicines in treatment of various chronic diseases such as cancer also fuels the growth of the market. In addition, increase in technological advancements associated with in vitro diagnostic products, technologies, and software & services boosts the market growth. However, stringent government regulations and unfavorable reimbursement policies are anticipated to restrict the growth of the in vitro diagnostics market. On the contrary, high growth rates exhibited by developing economies present lucrative opportunities for key players in the in vitro diagnostics market during the forecast period.

 

In Vitro Diagnostics (Ivd) Market Segmentation  

The report segments the market into product & service, technique, application, end user, and region. On the basis of product & service, the market is segmented into reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELISA segment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.

The clinical chemistry segment is further divided into basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, specialty chemicals, and others.

On the basis of application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. On the basis of end users, it is categorized into standalone laboratories, hospitals, academics & medical schools, point-of-care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

 

Segment Review

On the basis of product & service, the reagents segment acquired major in vitro diagnostics market share of the market. The growth of this segment is attributed to the fact that reagents are a vital part of every in vitro diagnostic test. Hence, the aforementioned factors contribute to the growth of this segment. In addition, the instruments segment is expected to grow at the fastest CAGR during the forecast period, owing to rise in focus of key players toward launching of new instruments. 

 

By application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. The infectious diseases market has the highest potential, owing to increase in incidences of HIV-AIDS, hepatitis, and other infectious diseases.    

 

North America is expected to be the leading regional market for in vitro diagnostics during the forecast period, owing to its well-penetrated healthcare system and higher healthcare awareness among patients, including Obama’s Affordable Care Act (ACA) act, change in technology, and rebounding American Economy. Furthermore, other factors such as easy availability of devices, rise in awareness related to use of these products, and presence of a large number of geriatric populations suffering from various chronic diseases also contribute to the growth of the market. Moreover, the presence of a large number of key players in North America is another major factor that drives the in vitro diagnostics market growth. In addition, Asia-Pacific is expected to register fastest growth during the forecast period, owing to surge in healthcare expenditure and rise in prevalence of diabetes in the region. Other factors such as a huge patient base of other chronic diseases that require IVD testing also boost the growth of the market in Asia-Pacific. 

 

The global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

 

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global in vitro diagnostics market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The in vitro diagnostics market forecast is studied from 2020 to 2027. 
  • The in vitro diagnostics market size and estimations are based on a comprehensive analysis of key developments in the industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Product & Service

  • Reagents
  • Instruments
  • Software and Services

 

By Technique

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence immunoassay (FIA)    
      • Colorimetric Immunoassay (CI)
    • Rapid Tests
    • Enzyme-Linked ImmunoSpot (ELISPOT)    
    • Radioimmunoassay (RIA)
    • Western Blot
  • Hematology
  • Molecular Diagnostics
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA diagnostics
    • Microarray
    • Others
  • Tissue Diagnostics
    • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Electrolyte Panel    
    • Specialty Chemicals
  • Others

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases 
  • Gastrointestinal Diseases
  • Others

 

By End User 

  • Standalone Laboratories
  • Hospitals
  • Academic & Medical Schools
  • Point-of-Care
  • Others

 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA

 

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies, 2019
3.4. Top player positioning, 2019
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in incidence of chronic and infectious diseases
3.6.1.2. Technological advancements in IVD
3.6.1.3. Emergence of minimal invasive technologies
3.6.1.4. Increasing government expenditures on healthcare
3.6.1.5. Increase in popularity of personalized medicine approach
3.6.2. Restraint
3.6.2.1. Unclear reimbursement policies
3.6.2.2. Stringent regulatory policies
3.6.3. Opportunities
3.6.3.1. Potential opportunities for outsourcing
3.6.3.2. Convergence of new technologies
3.6.4. Impact Analyses
CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunodiagnostics
5.2.1. Market size and forecast, by type
5.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.1.1.1. Market size and forecast
5.2.1.1.2. Chemiluminescence Immunoassay (CLIA)
5.2.1.1.2.1. Market size and forecast
5.2.1.1.3. Fluorescence Immunoassay (FIA)
5.2.1.1.3.1. Market size and forecast
5.2.1.1.4. Colorimetric Immunoassay (CI)
5.2.1.1.4.1. Market size and forecast
5.2.1.2. Rapid Tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.1.3.1. Market size and forecast
5.2.1.4. Radioimmunoassay (RIA)
5.2.1.4.1. Market size and forecast
5.2.1.5. Western Blot
5.2.1.5.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Hematology
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Molecular Diagnostics
5.4.1. Market size and forecast, by type
5.4.1.1. Polymerize Chain Reaction (PCR)
5.4.1.1.1. Market size and forecast
5.4.1.2. Isothermal Nucleic Acid Technology (INAAT)
5.4.1.2.1. Market size and forecast
5.4.1.3. Hybridization
5.4.1.3.1. Market size and forecast
5.4.1.4. DNA Diagnostics
5.4.1.4.1. Market size and forecast
5.4.1.5. Microarray
5.4.1.5.1. Market size and forecast
5.4.1.6. Others
5.4.1.6.1. Market size and forecast
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country
5.5. Tissue Diagnostics
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Clinical Chemistry
5.6.1. Market size and forecast, by type
5.6.1.1. Basic Metabolic Panel
5.6.1.1.1. Market size and forecast
5.6.1.2. Liver Panel
5.6.1.2.1. Market size and forecast
5.6.1.3. Renal Profile
5.6.1.3.1. Market size and forecast
5.6.1.4. Lipid Profile
5.6.1.4.1. Market size and forecast
5.6.1.5. Thyroid Function Panel
5.6.1.5.1. Market size and forecast
5.6.1.6. Electrolyte Panel
5.6.1.6.1. Market size and forecast
5.6.1.7. Specialty Chemicals
5.6.1.7.1. Market size and forecast
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis, by country
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis, by country
CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Diseases
6.2.1. Market size and forecast, by region
6.2.2. Market share analysis
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Cardiac Diseases
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Immune System Disorders
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Nephrological Diseases
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis
6.7. Gastrointestinal Diseases
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis
6.8. Others
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis
CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Stand-Alone Laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Hospitals
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Academic & Medical Schools
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Point of Care Testing
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
7.6. Others
7.6.1. Market size and forecast, by region
7.6.2. Market share analysis, by country
CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. In-vitro diagnostics market, by product type
8.2.2.1.2. U.S. In-vitro diagnostics market, by technique
8.2.2.1.3. U.S. In-vitro diagnostics market, by application
8.2.2.1.4. U.S. In-vitro diagnostics market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada In-vitro diagnostics market, by product type
8.2.2.2.2. Canada In-vitro diagnostics market, by technique
8.2.2.2.3. Canada In-vitro diagnostics market, by application
8.2.2.2.4. Canada In-vitro diagnostics market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico In-vitro diagnostics market, by product type
8.2.2.3.2. Mexico In-vitro diagnostics market, by technique
8.2.2.3.3. Mexico In-vitro diagnostics market, by application
8.2.2.3.4. Mexico In-vitro diagnostics market, by end user
8.2.3. Market size and forecast, by product type
8.2.4. Market size and forecast, by technique
8.2.5. Market size and forecast, by application
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany In-vitro diagnostics market, by product type
8.3.2.1.2. Germany In-vitro diagnostics market, by technique
8.3.2.1.3. Germany In-vitro diagnostics market, by application
8.3.2.1.4. Germany In-vitro diagnostics market, by end user
8.3.2.2. France
8.3.2.2.1. France In-vitro diagnostics market, by product type
8.3.2.2.2. France In-vitro diagnostics market, by technique
8.3.2.2.3. France In-vitro diagnostics market, by application
8.3.2.2.4. France In-vitro diagnostics market, by end user
8.3.2.3. UK
8.3.2.3.1. UK In-vitro diagnostics market, by product type
8.3.2.3.2. UK In-vitro diagnostics market, by technique
8.3.2.3.3. UK In-vitro diagnostics market, by application
8.3.2.3.4. UK In-vitro diagnostics market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy In-vitro diagnostics market, by product type
8.3.2.4.2. Italy In-vitro diagnostics market, by technique
8.3.2.4.3. Italy In-vitro diagnostics market, by application
8.3.2.4.4. Italy In-vitro diagnostics market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain In-vitro diagnostics market, by product type
8.3.2.5.2. Spain In-vitro diagnostics market, by technique
8.3.2.5.3. Spain In-vitro diagnostics market, by application
8.3.2.5.4. Spain In-vitro diagnostics market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe In-vitro diagnostics market, by product t type
8.3.2.6.2. Rest of Europe In-vitro diagnostics market, by technique
8.3.2.6.3. Rest of Europe In-vitro diagnostics market, by application
8.3.2.6.4. Rest of Europe In-vitro diagnostics market, by end user
8.3.3. Market size and forecast, by product type
8.3.4. Market size and forecast, by technique
8.3.5. Market size and forecast, by application
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan In-vitro diagnostics market, by product type
8.4.2.1.2. Japan In-vitro diagnostics market, by technique
8.4.2.1.3. Japan In-vitro diagnostics market, by application
8.4.2.1.4. Japan In-vitro diagnostics market, by end user
8.4.2.2. China
8.4.2.2.1. China In-vitro diagnostics market, by product type
8.4.2.2.2. China In-vitro diagnostics market, by technique
8.4.2.2.3. China In-vitro diagnostics market, by application
8.4.2.2.4. China In-vitro diagnostics market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia In-vitro diagnostics market, by product type
8.4.2.3.2. Australia In-vitro diagnostics market, by technique
8.4.2.3.3. Australia In-vitro diagnostics market, by application
8.4.2.3.4. Australia In-vitro diagnostics market, by end user
8.4.2.4. India
8.4.2.4.1. India In-vitro diagnostics market, by product type
8.4.2.4.2. India In-vitro diagnostics market, by technique
8.4.2.4.3. India In-vitro diagnostics market, by application
8.4.2.4.4. India In-vitro diagnostics market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea In-vitro diagnostics market, by product type
8.4.2.5.2. South Korea In-vitro diagnostics market, by technique
8.4.2.5.3. South Korea In-vitro diagnostics market, by application
8.4.2.5.4. South Korea In-vitro diagnostics market, by end user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific In-vitro diagnostics market, by product type
8.4.2.6.2. Rest of Asia-Pacific In-vitro diagnostics market, by technique
8.4.2.6.3. Rest of Asia-Pacific In-vitro diagnostics market, by application
8.4.2.6.4. Rest of Asia-Pacific In-vitro diagnostics market, by end user
8.4.3. Market size and forecast, by product type
8.4.4. Market size and forecast, by technique
8.4.5. Market size and forecast, by indication
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil In-vitro diagnostics market, by product type
8.5.2.1.2. Brazil In-vitro diagnostics market, by technique
8.5.2.1.3. Brazil In-vitro diagnostics market, by application
8.5.2.1.4. Brazil In-vitro diagnostics market, by end user
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia In-vitro diagnostics market, by product type
8.5.2.2.3. Saudi Arabia In-vitro diagnostics market, by technique
8.5.2.2.4. Saudi Arabia In-vitro diagnostics market, by application
8.5.2.2.5. Saudi Arabia In-vitro diagnostics market, by end user
8.5.2.3. South Africa
8.5.2.3.1. South Africa In-vitro diagnostics market, by product type
8.5.2.3.2. South Africa In-vitro diagnostics market, by technique
8.5.2.3.3. South Africa In-vitro diagnostics market, by application
8.5.2.3.4. South Africa In-vitro diagnostics market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA In-vitro diagnostics market, by product type
8.5.2.4.2. Rest of LAMEA In-vitro diagnostics market, by technique
8.5.2.4.3. Rest of LAMEA In-vitro diagnostics market, by application
8.5.2.4.4. Rest of LAMEA In-vitro diagnostics market, by end user
8.5.3. Market size and forecast, by product type
8.5.4. Market size and forecast, by technique
8.5.5. Market size and forecast, by application
8.5.6. Market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. Becton, Dickinson and Company
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. bioMrieux SA
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product type portfolio
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product type Portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Danaher Corporation (Beckman Coulter, Inc.)
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product type portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. F. Hoffmann-La Roche Ltd.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product type portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Johnson & Johnson
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product type Portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. QIAGEN N.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Sysmex Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product type Portfolio
9.9.5. Business performance
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product type Portfolio
9.10.5. Business performance
            9.10.6. Key strategic moves and development
LIST OF TABLES
 
TABLE 01. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 02. IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 20162023 ($MILLION)
TABLE 03. IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 20172025 ($MILLION)
TABLE 04. IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 06. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY TYPE, 20172025 ($MILLION)
TABLE 07. IN-VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 20172025 ($MILLION)
TABLE 08. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 09. IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 20172025 ($MILLION)
TABLE 10. MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 11. IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 12. IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 13. CLINICAL CHEMISTRY MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 14. IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 20172025 ($MILLION)
TABLE 15. IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 17. IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,20172025 ($MILLION)
TABLE 18. IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 20172025 ($MILLION)
TABLE 19. IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 20. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 20172025 ($MILLION)
TABLE 21. IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 22. IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 23. IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY REGION, 20172025 ($MILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 25. IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY REGION, 20172025 ($MILLION)
TABLE 26. IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 20172025 ($MILLION)
TABLE 27. IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION, 20172025 ($MILLION)
TABLE 28. IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY REGION, 20172025 ($MILLION)
TABLE 29. IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 30. IN-VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 31. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 32. U.S. IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 33. U.S. IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 34. U.S. IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 35. U.S. IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 36. CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 37. CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 38. CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 39. CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 40. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 41. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 42. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 43. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 44. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 45. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 46. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 47. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 48. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 49. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 50. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 51. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 52. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 53. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 54. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 55. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 56. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 57. UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 58. UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 59. UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 60. UK IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 61. ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 62. ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 63. ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 64. ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 65. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 66. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 67. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 68. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 69. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 70. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 71. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 72. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 73. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 74. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 75. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 76. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 77. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 78. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 79. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 80. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 81. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 82. CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 83. CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 84. CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 85. CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 86. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 87. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 88. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 89. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 90. INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 91. INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 92. INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 93. INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 94. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 95. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 96. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 97. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 98. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 99. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 100. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 101. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 102. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 103. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 104. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 105. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 106. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 107. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 108. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 109. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 110. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 111. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 112. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 113. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 114. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 115. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 116. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 117. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 118. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 119. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 120. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 121. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 122. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 123. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 124. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 125. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 126. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 127. ABBOTT: COMPANY SNAPSHOT
TABLE 128. ABBOTT: OPERATING SEGMENTS
TABLE 129. ABBOTT: PRODUCT TYPE PORTFOLIO
TABLE 130. BD : COMPANY SNAPSHOT
TABLE 131. BD : OPERATING SEGMENTS
TABLE 132. BD : PRODUCT TYPE PORTFOLIO
TABLE 133. BIOMRIEUX: COMPANY SNAPSHOT
TABLE 134. BIOMRIEUX: PRODUCT TYPE PORTFOLIO
TABLE 135. BIO-RAD: COMPANY SNAPSHOT
TABLE 136. BIO-RAD: OPERATING SEGMENTS
TABLE 137. BIO-RAD: PRODUCT TYPE PORTFOLIO
TABLE 138. DANAHER: COMPANY SNAPSHOT
TABLE 139. DANAHER: OPERATING SEGMENTS
TABLE 140. DANAHER: PRODUCT TYPE PORTFOLIO
TABLE 141. ROCHE: COMPANY SNAPSHOT
TABLE 142. ROCHE: OPERATING SEGMENTS
TABLE 143. ROCHE: PRODUCT TYPE PORTFOLIO
TABLE 144. J&J: COMPANY SNAPSHOT
TABLE 145. J&J: OPERATING SEGMENTS
TABLE 146. J&J: PRODUCT TYPE PORTFOLIO
TABLE 147. QIAGEN: COMPANY SNAPSHOT
TABLE 148. QIAGEN: PRODUCT TYPE PORTFOLIO
TABLE 149. SYSMEX: COMPANY SNAPSHOT
TABLE 150. SYSMEX: PRODUCT TYPE PORTFOLIO
TABLE 151. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 152. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 153. THERMO FISHER SCIENTIFIC: PRODUCT TYPE PORTFOLIO LIST OF FIGURES
 
FIGURE 01. IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, 2015-2018
FIGURE 04. FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2015-2018
FIGURE 05. TOP PLAYER POSITIONING, 2017
FIGURE 06. MODERATE BARGANING POWER OF BUYERS
FIGURE 07. HIGH BARGANING POWER OF SUPPLIERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTION
FIGURE 09. LOW THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. IMPACT ANALYSES, IN-VITRO DIAGNOSTICS MARKET
FIGURE 12. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2017 & 2025
FIGURE 13. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
FIGURE 14. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2017 & 2025
FIGURE 15. CHEMILUMINESCENCE IMMUNOASSAY (CLIA) MARKET, 20172025 ($MILLION)
FIGURE 16. FLUORESENCE IMMUNOASSAY (FIA) MARKET, 20172025 ($MILLION)
FIGURE 17. COLORIMETRIC IMMUNOASSAYS (CI) MARKET, 20172025 ($MILLION)
FIGURE 18. IMMUNO-DIAGNOSTICS MARKET FOR RAPID TESTS, 20172025 ($MILLION)
FIGURE 19. IMMUNO-DIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 20172025 ($MILLION)
FIGURE 20. IMMUNO-DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAYS (RIA), 20172025 ($MILLION)
FIGURE 21. IMMUNO-DIAGNOSTICS MARKET FOR WESTERN BLOT, 20172025 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 23. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2017 & 2025
FIGURE 24. MOLECULAR DIAGNOSTICS MARKET FOR POLYMERIZE CHAIN REACTION (PCR), 20172025 ($MILLION)
FIGURE 25. MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT), 20172025 ($MILLION)
FIGURE 26. MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 20172025 ($MILLION)
FIGURE 27. MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 20172025 ($MILLION)
FIGURE 28. MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 20172025 ($MILLION)
FIGURE 29. MOLECULAR DIAGNOSTICS MARKET FOR OTHERS, 20172025 ($MILLION)
FIGURE 30. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 31. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 32. CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 20172025 ($MILLION)
FIGURE 33. CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 20172025 ($MILLION)
FIGURE 34. CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 20172025 ($MILLION)
FIGURE 35. CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 20172025 ($MILLION)
FIGURE 36. CLINICAL CHEMISTRY MARKET FOR THYROID FUNCTION PANEL, 20172025 ($MILLION)
FIGURE 37. CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 20172025 ($MILLION)
FIGURE 38. CLINICAL CHEMISTRY MARKET FOR SPECIALTY CHEMICALS, 20172025 ($MILLION)
FIGURE 39. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2017 & 2025
FIGURE 40. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY COUNTRY, 2017 & 2025
FIGURE 41. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 42. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2017 & 2025
FIGURE 43. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 44. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY, 2017 & 2025
FIGURE 45. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 46. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 47. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017 & 2025
FIGURE 48. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY COUNTRY, 2017 & 2025
FIGURE 49. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025
FIGURE 50. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY, 2017 & 2025
FIGURE 51. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY COUNTRY, 2017 & 2025
FIGURE 52. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
FIGURE 53. EUROPEAN GERIATRIC POPULATION (ABOVE 65 YEARS), 2017
FIGURE 54. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 55. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
FIGURE 56. ABBOTT: NET SALES SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 57. BD: REVENUE, 20152017 ($MILLION)
FIGURE 58. BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59. BD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60. BIOMRIEUX: NET SALES, 20152017 ($MILLION)
FIGURE 61. BIOMRIEUX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 62. BIO-RAD: NET SALES, 20152017 ($MILLION)
FIGURE 63. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 64. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 65. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 66. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 67. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 68. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 69. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 70. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 71. J&J: REVENUE, 20152017 ($MILLION)
FIGURE 72. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 73. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 74. QIAGEN: NET SALES, 20152017 ($MILLION)
FIGURE 75. QIAGEN: REVENUE SHARE BY PRODUCT TYPE, 2017 (%)
FIGURE 76. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 77. SYSMEX: REVENUE, 20152017 ($MILLION)
FIGURE 78. SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 79. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
FIGURE 80. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 81. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY GEOGRAPHY, 2017 (%

In Vitro Diagnostics (IVD) Market Overview:

 

The global in vitro diagnostics (IVD) market size was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. 

 

In vitro diagnostics (IVD) are medical devices, which require use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples collected from a patient. In addition, there are various types of in vitro diagnostic instruments that work on different techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are employed in diagnosis of various medical conditions such as infectious diseases, cancer, cardiac disorders, and nephrological disorders.  Moreover, use and handling of in vitro diagnostics require technical expertise and thus, instruments are used in specialized medical facilities to carry out diagnosis. For instance, IVD products are used in facilities such as standalone laboratories, hospitals, and point-of care. 

 

The major factor that contributes to the in vitro diagnostics market growth of the in vitro diagnostic market include surge in number of in vitro diagnostic tests, which is attributable to rise in incidences of chronic and infectious diseases. Furthermore, growth in geriatric population, which is prone to immunological disorders, is another major factor that boosts the growth of the market. Moreover, rise in use of personalized medicines in treatment of various chronic diseases such as cancer also fuels the growth of the market. In addition, increase in technological advancements associated with in vitro diagnostic products, technologies, and software & services boosts the market growth. However, stringent government regulations and unfavorable reimbursement policies are anticipated to restrict the growth of the in vitro diagnostics market. On the contrary, high growth rates exhibited by developing economies present lucrative opportunities for key players in the in vitro diagnostics market during the forecast period.

 

In Vitro Diagnostics (Ivd) Market Segmentation  

The report segments the market into product & service, technique, application, end user, and region. On the basis of product & service, the market is segmented into reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELISA segment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.

The clinical chemistry segment is further divided into basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, specialty chemicals, and others.

On the basis of application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. On the basis of end users, it is categorized into standalone laboratories, hospitals, academics & medical schools, point-of-care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

 

Segment Review

On the basis of product & service, the reagents segment acquired major in vitro diagnostics market share of the market. The growth of this segment is attributed to the fact that reagents are a vital part of every in vitro diagnostic test. Hence, the aforementioned factors contribute to the growth of this segment. In addition, the instruments segment is expected to grow at the fastest CAGR during the forecast period, owing to rise in focus of key players toward launching of new instruments. 

 

By application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. The infectious diseases market has the highest potential, owing to increase in incidences of HIV-AIDS, hepatitis, and other infectious diseases.    

 

North America is expected to be the leading regional market for in vitro diagnostics during the forecast period, owing to its well-penetrated healthcare system and higher healthcare awareness among patients, including Obama’s Affordable Care Act (ACA) act, change in technology, and rebounding American Economy. Furthermore, other factors such as easy availability of devices, rise in awareness related to use of these products, and presence of a large number of geriatric populations suffering from various chronic diseases also contribute to the growth of the market. Moreover, the presence of a large number of key players in North America is another major factor that drives the in vitro diagnostics market growth. In addition, Asia-Pacific is expected to register fastest growth during the forecast period, owing to surge in healthcare expenditure and rise in prevalence of diabetes in the region. Other factors such as a huge patient base of other chronic diseases that require IVD testing also boost the growth of the market in Asia-Pacific. 

 

The global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

 

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global in vitro diagnostics market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The in vitro diagnostics market forecast is studied from 2020 to 2027. 
  • The in vitro diagnostics market size and estimations are based on a comprehensive analysis of key developments in the industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Product & Service

  • Reagents
  • Instruments
  • Software and Services

 

By Technique

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence immunoassay (FIA)    
      • Colorimetric Immunoassay (CI)
    • Rapid Tests
    • Enzyme-Linked ImmunoSpot (ELISPOT)    
    • Radioimmunoassay (RIA)
    • Western Blot
  • Hematology
  • Molecular Diagnostics
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA diagnostics
    • Microarray
    • Others
  • Tissue Diagnostics
    • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Electrolyte Panel    
    • Specialty Chemicals
  • Others

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases 
  • Gastrointestinal Diseases
  • Others

 

By End User 

  • Standalone Laboratories
  • Hospitals
  • Academic & Medical Schools
  • Point-of-Care
  • Others

 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA

 

Read More
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies, 2019
3.4. Top player positioning, 2019
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in incidence of chronic and infectious diseases
3.6.1.2. Technological advancements in IVD
3.6.1.3. Emergence of minimal invasive technologies
3.6.1.4. Increasing government expenditures on healthcare
3.6.1.5. Increase in popularity of personalized medicine approach
3.6.2. Restraint
3.6.2.1. Unclear reimbursement policies
3.6.2.2. Stringent regulatory policies
3.6.3. Opportunities
3.6.3.1. Potential opportunities for outsourcing
3.6.3.2. Convergence of new technologies
3.6.4. Impact Analyses
CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunodiagnostics
5.2.1. Market size and forecast, by type
5.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.1.1.1. Market size and forecast
5.2.1.1.2. Chemiluminescence Immunoassay (CLIA)
5.2.1.1.2.1. Market size and forecast
5.2.1.1.3. Fluorescence Immunoassay (FIA)
5.2.1.1.3.1. Market size and forecast
5.2.1.1.4. Colorimetric Immunoassay (CI)
5.2.1.1.4.1. Market size and forecast
5.2.1.2. Rapid Tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.1.3.1. Market size and forecast
5.2.1.4. Radioimmunoassay (RIA)
5.2.1.4.1. Market size and forecast
5.2.1.5. Western Blot
5.2.1.5.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Hematology
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Molecular Diagnostics
5.4.1. Market size and forecast, by type
5.4.1.1. Polymerize Chain Reaction (PCR)
5.4.1.1.1. Market size and forecast
5.4.1.2. Isothermal Nucleic Acid Technology (INAAT)
5.4.1.2.1. Market size and forecast
5.4.1.3. Hybridization
5.4.1.3.1. Market size and forecast
5.4.1.4. DNA Diagnostics
5.4.1.4.1. Market size and forecast
5.4.1.5. Microarray
5.4.1.5.1. Market size and forecast
5.4.1.6. Others
5.4.1.6.1. Market size and forecast
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country
5.5. Tissue Diagnostics
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Clinical Chemistry
5.6.1. Market size and forecast, by type
5.6.1.1. Basic Metabolic Panel
5.6.1.1.1. Market size and forecast
5.6.1.2. Liver Panel
5.6.1.2.1. Market size and forecast
5.6.1.3. Renal Profile
5.6.1.3.1. Market size and forecast
5.6.1.4. Lipid Profile
5.6.1.4.1. Market size and forecast
5.6.1.5. Thyroid Function Panel
5.6.1.5.1. Market size and forecast
5.6.1.6. Electrolyte Panel
5.6.1.6.1. Market size and forecast
5.6.1.7. Specialty Chemicals
5.6.1.7.1. Market size and forecast
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis, by country
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis, by country
CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Diseases
6.2.1. Market size and forecast, by region
6.2.2. Market share analysis
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Cardiac Diseases
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Immune System Disorders
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Nephrological Diseases
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis
6.7. Gastrointestinal Diseases
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis
6.8. Others
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis
CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Stand-Alone Laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Hospitals
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Academic & Medical Schools
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Point of Care Testing
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
7.6. Others
7.6.1. Market size and forecast, by region
7.6.2. Market share analysis, by country
CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. In-vitro diagnostics market, by product type
8.2.2.1.2. U.S. In-vitro diagnostics market, by technique
8.2.2.1.3. U.S. In-vitro diagnostics market, by application
8.2.2.1.4. U.S. In-vitro diagnostics market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada In-vitro diagnostics market, by product type
8.2.2.2.2. Canada In-vitro diagnostics market, by technique
8.2.2.2.3. Canada In-vitro diagnostics market, by application
8.2.2.2.4. Canada In-vitro diagnostics market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico In-vitro diagnostics market, by product type
8.2.2.3.2. Mexico In-vitro diagnostics market, by technique
8.2.2.3.3. Mexico In-vitro diagnostics market, by application
8.2.2.3.4. Mexico In-vitro diagnostics market, by end user
8.2.3. Market size and forecast, by product type
8.2.4. Market size and forecast, by technique
8.2.5. Market size and forecast, by application
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany In-vitro diagnostics market, by product type
8.3.2.1.2. Germany In-vitro diagnostics market, by technique
8.3.2.1.3. Germany In-vitro diagnostics market, by application
8.3.2.1.4. Germany In-vitro diagnostics market, by end user
8.3.2.2. France
8.3.2.2.1. France In-vitro diagnostics market, by product type
8.3.2.2.2. France In-vitro diagnostics market, by technique
8.3.2.2.3. France In-vitro diagnostics market, by application
8.3.2.2.4. France In-vitro diagnostics market, by end user
8.3.2.3. UK
8.3.2.3.1. UK In-vitro diagnostics market, by product type
8.3.2.3.2. UK In-vitro diagnostics market, by technique
8.3.2.3.3. UK In-vitro diagnostics market, by application
8.3.2.3.4. UK In-vitro diagnostics market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy In-vitro diagnostics market, by product type
8.3.2.4.2. Italy In-vitro diagnostics market, by technique
8.3.2.4.3. Italy In-vitro diagnostics market, by application
8.3.2.4.4. Italy In-vitro diagnostics market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain In-vitro diagnostics market, by product type
8.3.2.5.2. Spain In-vitro diagnostics market, by technique
8.3.2.5.3. Spain In-vitro diagnostics market, by application
8.3.2.5.4. Spain In-vitro diagnostics market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe In-vitro diagnostics market, by product t type
8.3.2.6.2. Rest of Europe In-vitro diagnostics market, by technique
8.3.2.6.3. Rest of Europe In-vitro diagnostics market, by application
8.3.2.6.4. Rest of Europe In-vitro diagnostics market, by end user
8.3.3. Market size and forecast, by product type
8.3.4. Market size and forecast, by technique
8.3.5. Market size and forecast, by application
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan In-vitro diagnostics market, by product type
8.4.2.1.2. Japan In-vitro diagnostics market, by technique
8.4.2.1.3. Japan In-vitro diagnostics market, by application
8.4.2.1.4. Japan In-vitro diagnostics market, by end user
8.4.2.2. China
8.4.2.2.1. China In-vitro diagnostics market, by product type
8.4.2.2.2. China In-vitro diagnostics market, by technique
8.4.2.2.3. China In-vitro diagnostics market, by application
8.4.2.2.4. China In-vitro diagnostics market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia In-vitro diagnostics market, by product type
8.4.2.3.2. Australia In-vitro diagnostics market, by technique
8.4.2.3.3. Australia In-vitro diagnostics market, by application
8.4.2.3.4. Australia In-vitro diagnostics market, by end user
8.4.2.4. India
8.4.2.4.1. India In-vitro diagnostics market, by product type
8.4.2.4.2. India In-vitro diagnostics market, by technique
8.4.2.4.3. India In-vitro diagnostics market, by application
8.4.2.4.4. India In-vitro diagnostics market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea In-vitro diagnostics market, by product type
8.4.2.5.2. South Korea In-vitro diagnostics market, by technique
8.4.2.5.3. South Korea In-vitro diagnostics market, by application
8.4.2.5.4. South Korea In-vitro diagnostics market, by end user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific In-vitro diagnostics market, by product type
8.4.2.6.2. Rest of Asia-Pacific In-vitro diagnostics market, by technique
8.4.2.6.3. Rest of Asia-Pacific In-vitro diagnostics market, by application
8.4.2.6.4. Rest of Asia-Pacific In-vitro diagnostics market, by end user
8.4.3. Market size and forecast, by product type
8.4.4. Market size and forecast, by technique
8.4.5. Market size and forecast, by indication
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil In-vitro diagnostics market, by product type
8.5.2.1.2. Brazil In-vitro diagnostics market, by technique
8.5.2.1.3. Brazil In-vitro diagnostics market, by application
8.5.2.1.4. Brazil In-vitro diagnostics market, by end user
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia In-vitro diagnostics market, by product type
8.5.2.2.3. Saudi Arabia In-vitro diagnostics market, by technique
8.5.2.2.4. Saudi Arabia In-vitro diagnostics market, by application
8.5.2.2.5. Saudi Arabia In-vitro diagnostics market, by end user
8.5.2.3. South Africa
8.5.2.3.1. South Africa In-vitro diagnostics market, by product type
8.5.2.3.2. South Africa In-vitro diagnostics market, by technique
8.5.2.3.3. South Africa In-vitro diagnostics market, by application
8.5.2.3.4. South Africa In-vitro diagnostics market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA In-vitro diagnostics market, by product type
8.5.2.4.2. Rest of LAMEA In-vitro diagnostics market, by technique
8.5.2.4.3. Rest of LAMEA In-vitro diagnostics market, by application
8.5.2.4.4. Rest of LAMEA In-vitro diagnostics market, by end user
8.5.3. Market size and forecast, by product type
8.5.4. Market size and forecast, by technique
8.5.5. Market size and forecast, by application
8.5.6. Market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. Becton, Dickinson and Company
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. bioMrieux SA
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product type portfolio
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product type Portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Danaher Corporation (Beckman Coulter, Inc.)
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product type portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. F. Hoffmann-La Roche Ltd.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product type portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Johnson & Johnson
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product type Portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. QIAGEN N.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Sysmex Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product type Portfolio
9.9.5. Business performance
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product type Portfolio
9.10.5. Business performance
            9.10.6. Key strategic moves and development
Read More
LIST OF TABLES
 
TABLE 01. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 02. IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 20162023 ($MILLION)
TABLE 03. IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 20172025 ($MILLION)
TABLE 04. IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 06. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY TYPE, 20172025 ($MILLION)
TABLE 07. IN-VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 20172025 ($MILLION)
TABLE 08. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 09. IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 20172025 ($MILLION)
TABLE 10. MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 11. IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 12. IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 13. CLINICAL CHEMISTRY MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 14. IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 20172025 ($MILLION)
TABLE 15. IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 17. IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,20172025 ($MILLION)
TABLE 18. IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 20172025 ($MILLION)
TABLE 19. IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 20. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 20172025 ($MILLION)
TABLE 21. IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 22. IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 23. IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY REGION, 20172025 ($MILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 25. IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY REGION, 20172025 ($MILLION)
TABLE 26. IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 20172025 ($MILLION)
TABLE 27. IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION, 20172025 ($MILLION)
TABLE 28. IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY REGION, 20172025 ($MILLION)
TABLE 29. IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 30. IN-VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 31. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 32. U.S. IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 33. U.S. IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 34. U.S. IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 35. U.S. IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 36. CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 37. CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 38. CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 39. CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 40. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 41. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 42. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 43. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 44. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 45. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 46. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 47. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 48. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 49. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 50. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 51. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 52. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 53. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 54. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 55. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 56. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 57. UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 58. UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 59. UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 60. UK IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 61. ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 62. ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 63. ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 64. ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 65. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 66. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 67. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 68. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 69. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 70. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 71. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 72. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 73. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 74. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 75. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 76. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 77. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 78. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 79. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 80. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 81. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 82. CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 83. CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 84. CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 85. CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 86. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 87. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 88. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 89. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 90. INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 91. INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 92. INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 93. INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 94. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 95. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 96. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 97. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 98. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 99. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 100. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 101. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 102. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 103. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 104. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 105. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 106. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 107. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 108. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 109. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 110. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 111. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 112. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 113. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 114. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 115. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 116. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 117. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 118. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 119. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 120. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 121. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 122. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 123. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
TABLE 124. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
TABLE 125. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 126. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 127. ABBOTT: COMPANY SNAPSHOT
TABLE 128. ABBOTT: OPERATING SEGMENTS
TABLE 129. ABBOTT: PRODUCT TYPE PORTFOLIO
TABLE 130. BD : COMPANY SNAPSHOT
TABLE 131. BD : OPERATING SEGMENTS
TABLE 132. BD : PRODUCT TYPE PORTFOLIO
TABLE 133. BIOMRIEUX: COMPANY SNAPSHOT
TABLE 134. BIOMRIEUX: PRODUCT TYPE PORTFOLIO
TABLE 135. BIO-RAD: COMPANY SNAPSHOT
TABLE 136. BIO-RAD: OPERATING SEGMENTS
TABLE 137. BIO-RAD: PRODUCT TYPE PORTFOLIO
TABLE 138. DANAHER: COMPANY SNAPSHOT
TABLE 139. DANAHER: OPERATING SEGMENTS
TABLE 140. DANAHER: PRODUCT TYPE PORTFOLIO
TABLE 141. ROCHE: COMPANY SNAPSHOT
TABLE 142. ROCHE: OPERATING SEGMENTS
TABLE 143. ROCHE: PRODUCT TYPE PORTFOLIO
TABLE 144. J&J: COMPANY SNAPSHOT
TABLE 145. J&J: OPERATING SEGMENTS
TABLE 146. J&J: PRODUCT TYPE PORTFOLIO
TABLE 147. QIAGEN: COMPANY SNAPSHOT
TABLE 148. QIAGEN: PRODUCT TYPE PORTFOLIO
TABLE 149. SYSMEX: COMPANY SNAPSHOT
TABLE 150. SYSMEX: PRODUCT TYPE PORTFOLIO
TABLE 151. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 152. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 153. THERMO FISHER SCIENTIFIC: PRODUCT TYPE PORTFOLIO LIST OF FIGURES
 
FIGURE 01. IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, 2015-2018
FIGURE 04. FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2015-2018
FIGURE 05. TOP PLAYER POSITIONING, 2017
FIGURE 06. MODERATE BARGANING POWER OF BUYERS
FIGURE 07. HIGH BARGANING POWER OF SUPPLIERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTION
FIGURE 09. LOW THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. IMPACT ANALYSES, IN-VITRO DIAGNOSTICS MARKET
FIGURE 12. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2017 & 2025
FIGURE 13. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
FIGURE 14. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2017 & 2025
FIGURE 15. CHEMILUMINESCENCE IMMUNOASSAY (CLIA) MARKET, 20172025 ($MILLION)
FIGURE 16. FLUORESENCE IMMUNOASSAY (FIA) MARKET, 20172025 ($MILLION)
FIGURE 17. COLORIMETRIC IMMUNOASSAYS (CI) MARKET, 20172025 ($MILLION)
FIGURE 18. IMMUNO-DIAGNOSTICS MARKET FOR RAPID TESTS, 20172025 ($MILLION)
FIGURE 19. IMMUNO-DIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 20172025 ($MILLION)
FIGURE 20. IMMUNO-DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAYS (RIA), 20172025 ($MILLION)
FIGURE 21. IMMUNO-DIAGNOSTICS MARKET FOR WESTERN BLOT, 20172025 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 23. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2017 & 2025
FIGURE 24. MOLECULAR DIAGNOSTICS MARKET FOR POLYMERIZE CHAIN REACTION (PCR), 20172025 ($MILLION)
FIGURE 25. MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT), 20172025 ($MILLION)
FIGURE 26. MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 20172025 ($MILLION)
FIGURE 27. MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 20172025 ($MILLION)
FIGURE 28. MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 20172025 ($MILLION)
FIGURE 29. MOLECULAR DIAGNOSTICS MARKET FOR OTHERS, 20172025 ($MILLION)
FIGURE 30. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 31. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 32. CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 20172025 ($MILLION)
FIGURE 33. CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 20172025 ($MILLION)
FIGURE 34. CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 20172025 ($MILLION)
FIGURE 35. CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 20172025 ($MILLION)
FIGURE 36. CLINICAL CHEMISTRY MARKET FOR THYROID FUNCTION PANEL, 20172025 ($MILLION)
FIGURE 37. CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 20172025 ($MILLION)
FIGURE 38. CLINICAL CHEMISTRY MARKET FOR SPECIALTY CHEMICALS, 20172025 ($MILLION)
FIGURE 39. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2017 & 2025
FIGURE 40. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY COUNTRY, 2017 & 2025
FIGURE 41. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 42. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2017 & 2025
FIGURE 43. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 44. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY, 2017 & 2025
FIGURE 45. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 46. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 47. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017 & 2025
FIGURE 48. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY COUNTRY, 2017 & 2025
FIGURE 49. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025
FIGURE 50. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY, 2017 & 2025
FIGURE 51. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY COUNTRY, 2017 & 2025
FIGURE 52. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
FIGURE 53. EUROPEAN GERIATRIC POPULATION (ABOVE 65 YEARS), 2017
FIGURE 54. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 55. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
FIGURE 56. ABBOTT: NET SALES SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 57. BD: REVENUE, 20152017 ($MILLION)
FIGURE 58. BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59. BD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60. BIOMRIEUX: NET SALES, 20152017 ($MILLION)
FIGURE 61. BIOMRIEUX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 62. BIO-RAD: NET SALES, 20152017 ($MILLION)
FIGURE 63. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 64. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 65. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 66. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 67. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 68. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 69. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 70. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 71. J&J: REVENUE, 20152017 ($MILLION)
FIGURE 72. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 73. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 74. QIAGEN: NET SALES, 20152017 ($MILLION)
FIGURE 75. QIAGEN: REVENUE SHARE BY PRODUCT TYPE, 2017 (%)
FIGURE 76. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 77. SYSMEX: REVENUE, 20152017 ($MILLION)
FIGURE 78. SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 79. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
FIGURE 80. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 81. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY GEOGRAPHY, 2017 (%
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$5370
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$6450
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$8995
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Lancing Devices for Flood Testing Market Insights and Forecast to 2026
Global Lancing Devices for Flood Testing Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-34L2952
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Sternal Closure Systems Market Insights and Forecast to 2026
Global Sternal Closure Systems Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-28P2961
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Sterile Filtration Market Insights and Forecast to 2026
Global Sterile Filtration Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-35G3019
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Traumatic Brain Injuries Treatment Market Size Status and Forecast 2020 2026
Global Traumatic Brain Injuries Treatment Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-13L3276
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0